This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Hanauer, Stephen
Item Type | Name |
Concept
|
Gastrointestinal Diseases
|
Academic Article
|
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
|
Academic Article
|
Infliximab in Crohn's disease: first anniversary clinical experience.
|
Academic Article
|
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Immunogenicity of infliximab in Crohn's disease.
|
Academic Article
|
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
|
Academic Article
|
Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
|
Academic Article
|
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
|
Academic Article
|
Safety first: messages from Digestive Disease Week 2006.
|
Academic Article
|
Emerging biologic therapies in inflammatory bowel disease.
|
Academic Article
|
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.
|
Academic Article
|
Moving ahead or falling behind?
|
Academic Article
|
The ethics of phase I trials of biologic agents.
|
Academic Article
|
Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
|
Academic Article
|
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
|
Academic Article
|
An evidence-based systematic review on medical therapies for inflammatory bowel disease.
|
Academic Article
|
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.
|
Academic Article
|
Practical application of anti-TNF therapy for luminal Crohn's disease.
|
Academic Article
|
What to take from TREAT?
|
Academic Article
|
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
|
Academic Article
|
Review article: safety of infliximab in clinical trials.
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
|
Academic Article
|
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.
|
Academic Article
|
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
|
Academic Article
|
Aminosalicylates for induction of remission or response in Crohn's disease.
|
Academic Article
|
Optimizing pharmacologic management of inflammatory bowel disease.
|
Academic Article
|
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
|
Academic Article
|
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
|
- Gastrointestinal Diseases